Adia Med unit Adia Labs expands regenerative research-use product line
ADIA•Adia Labs added three research-use products, including lower cell-count stem cells and new exosome formats, to broaden study-design choices for physicians using authorized protocols.
1. Three new offerings
Adia Med’s lab subsidiary, Adia Labs, expanded its regenerative research-use product lineup with three offerings: lower cell-count stem cells, an ophthalmic or otic exosome format, and a lower-concentration exosome option. The company positioned the additions to broaden study-design choices for physicians using IRB-approved or similarly authorized protocols.
